• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Cabot Corporation (Amendment)

    2/12/24 9:53:45 PM ET
    $CBT
    Major Chemicals
    Industrials
    Get the next $CBT alert in real time by email
    SC 13G/A 1 cbt13g2nd1223.txt CABOT CORPORATION - 12/31/2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No._2_) Cabot Corporation ------------------------------------------------------------------------------- (Name of Issuer) Common Stock ------------------------------------------------------------------------------- (Title of Class of Securities) 127055101 ------------------------------ (CUSIP Number) 12/31/2023 ------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) CUSIP NO. 127055101 --------- ------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). EARNEST Partners, LLC ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ------------------------------------------------------------------------------- 5 SOLE VOTING POWER 2,664,307 NUMBER OF ----------------------------------------------------------------- SHARES BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY ----------------------------------------------------------------- EACH REPORTING 7 SOLE DISPOSITIVE POWER 3,264,026 PERSON WITH ----------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,264,026 ------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)[ ] ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.9% ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) ------------------------------------------------------------------------------- IA ------------------------------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------------------------- Item 1 (a) Name of Issuer Cabot Corporation (b) Address of Issuer's Principal Executive Offices Two Seaport Lane, Suite 1400, Boston, Massachusetts, 02210-2019 Item 2 (a) Name of Person Filing EARNEST Partners, LLC (b) Address of Principal Business Office or, if none, Residence 1180 Peachtree Street NE, Suite 2300, Atlanta, Georgia 30309 (c) Citizenship Delaware (d) Title of Class of Securities Common Stock (e) CUSIP Number 127055101 Item 3. If this statement is filed pursuant to 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (b) [ ] Bank as defined in section 3(a)(6) of the Act (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (e) [X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 3,264,026 (b) Percent of class: 5.9% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 2,664,307 (ii) Shared power to vote or to direct the vote 0 (iii) Sole power to dispose or to direct the disposition of 3,264,026 (iv) Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ] Item 6. Ownership of More than Five Percent on Behalf of Another Person. EARNEST Partners, LLC is filing as an investment adviser in accordance with 240.13d-1(b)(1)(ii)(E). No client interest relates to more than five percent of the class. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of a Group Not Applicable Item 10. Certification (a) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(b): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. (b) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(c): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 12, 2024 ---------------------------------- Date /s/ James M. Wilson ---------------------------------- Signature James M. Wilson Chief Compliance Officer ---------------------------------- Name/Title Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001) ACN/Form 13G (C) 2006: Advisor Consultant Network, Inc.
    Get the next $CBT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CBT

    DatePrice TargetRatingAnalyst
    11/11/2024$105.00Neutral → Underweight
    JP Morgan
    4/18/2024Buy → Hold
    Deutsche Bank
    3/27/2024$104.00Buy
    Mizuho
    1/8/2024$90.00 → $87.00Buy → Neutral
    UBS
    6/6/2023$87.00 → $80.00Overweight → Neutral
    JP Morgan
    3/13/2023$94.00Outperform
    Credit Suisse
    11/16/2022$80.00 → $90.00Hold → Buy
    Deutsche Bank
    1/4/2022$75.00 → $70.00Buy
    UBS
    More analyst ratings

    $CBT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cabot Corp Reports Second Quarter Fiscal 2025 Results

      BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced results for its second quarter of fiscal year 2025. Key Highlights Diluted EPS of $1.69 and Adjusted EPS of $1.90 which represents a 7% increase in Adjusted EPS compared to the same quarter in the prior year Reinforcement Materials segment EBIT of $131 million; up 1% sequentially; down 12% compared to the same quarter in the prior year  Performance Chemicals segment EBIT of $50 million; up 11% sequentially; up 61% compared to the same quarter in the prior year  Returned $70 million of cash to shareholders in the second quarter through dividends and share repurchases  Increased quarterly dividend by 5% f

      5/5/25 4:30:41 PM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation Board Increases Dividend

      BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- On Monday, May 5, 2025, the Board of Directors of Cabot Corporation (NYSE:CBT) declared a quarterly dividend of $0.45 per share, an increase of 5% compared to the current quarterly dividend of $0.43 per share, on all outstanding shares of the Corporation's common stock. The dividend is payable on June 13, 2025, to stockholders of record at the close of business on May 30, 2025. "Today's announcement reflects the Board's confidence in our consistent earnings performance and our ability to generate strong cash flow," said Sean Keohane, President, and Chief Executive Officer of Cabot Corporation. "The dividend increase and the recent share repurchase

      5/5/25 4:26:16 PM ET
      $CBT
      Major Chemicals
      Industrials
    • ITT Nominates Douglas DelGrosso for Election to Board of Directors

      April 8, 2025-- ITT Inc. (NYSE: ITT) today announced the nomination of Douglas DelGrosso for election to its Board of Directors at the company's upcoming 2025 annual meeting of shareholders. Mr. DelGrosso served as president and chief executive officer of Adient plc (NYSE:ADNT), a global engineering and manufacturing company with operations in 29 countries, from October 2018 until his retirement in December 2023. "Over the last several years, the ITT Board has deliberately pursued a refreshment strategy to add seasoned operations executives to our Board with advanced expertise and skills. We are honored at the prospect of having Doug join ITT's Board of Directors and his election will mark

      4/8/25 8:05:00 AM ET
      $ADNT
      $CBT
      $ITT
      Auto Parts:O.E.M.
      Consumer Discretionary
      Major Chemicals
      Industrials

    $CBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cabot downgraded by JP Morgan with a new price target

      JP Morgan downgraded Cabot from Neutral to Underweight and set a new price target of $105.00

      11/11/24 7:37:34 AM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot downgraded by Deutsche Bank

      Deutsche Bank downgraded Cabot from Buy to Hold

      4/18/24 8:26:59 AM ET
      $CBT
      Major Chemicals
      Industrials
    • Mizuho initiated coverage on Cabot with a new price target

      Mizuho initiated coverage of Cabot with a rating of Buy and set a new price target of $104.00

      3/27/24 8:08:28 AM ET
      $CBT
      Major Chemicals
      Industrials

    $CBT
    Financials

    Live finance-specific insights

    See more
    • Cabot Corp Reports Second Quarter Fiscal 2025 Results

      BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced results for its second quarter of fiscal year 2025. Key Highlights Diluted EPS of $1.69 and Adjusted EPS of $1.90 which represents a 7% increase in Adjusted EPS compared to the same quarter in the prior year Reinforcement Materials segment EBIT of $131 million; up 1% sequentially; down 12% compared to the same quarter in the prior year  Performance Chemicals segment EBIT of $50 million; up 11% sequentially; up 61% compared to the same quarter in the prior year  Returned $70 million of cash to shareholders in the second quarter through dividends and share repurchases  Increased quarterly dividend by 5% f

      5/5/25 4:30:41 PM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation Board Increases Dividend

      BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- On Monday, May 5, 2025, the Board of Directors of Cabot Corporation (NYSE:CBT) declared a quarterly dividend of $0.45 per share, an increase of 5% compared to the current quarterly dividend of $0.43 per share, on all outstanding shares of the Corporation's common stock. The dividend is payable on June 13, 2025, to stockholders of record at the close of business on May 30, 2025. "Today's announcement reflects the Board's confidence in our consistent earnings performance and our ability to generate strong cash flow," said Sean Keohane, President, and Chief Executive Officer of Cabot Corporation. "The dividend increase and the recent share repurchase

      5/5/25 4:26:16 PM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation to Announce Second Quarter 2025 Operating Results

      BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) announced today that it will release operating results for the second quarter of fiscal 2025 on Monday, May 5, 2025, after market close. The Company will host a conference call and live webcast to review the second quarter results beginning at 8:00 am (ET) on Tuesday, May 6, 2025. The call will be webcast by Notified and may be accessed at Cabot's website at https://cabotog.gcs-web.com/. If you are unable to participate during the live webcast, the call and accompanying slide presentation will be archived on the Company's website at https://cabotog.gcs-web.com/. ABOUT CABOT CORPORATIONCabot Corporation (NYSE:CBT)

      4/2/25 7:50:14 AM ET
      $CBT
      Major Chemicals
      Industrials

    $CBT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cabot Corporation

      SC 13G/A - CABOT CORP (0000016040) (Subject)

      11/12/24 9:50:11 AM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Cabot Corporation (Amendment)

      SC 13G/A - CABOT CORP (0000016040) (Subject)

      2/12/24 9:53:45 PM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Cabot Corporation (Amendment)

      SC 13G/A - CABOT CORP (0000016040) (Subject)

      2/9/24 8:50:22 AM ET
      $CBT
      Major Chemicals
      Industrials

    $CBT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Nathoo Raffiq

      4 - CABOT CORP (0000016040) (Issuer)

      4/2/25 5:00:11 PM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form 4 filed by Director Enriquez Cabot Juan

      4 - CABOT CORP (0000016040) (Issuer)

      4/2/25 5:00:10 PM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form 4 filed by President and CEO Keohane Sean D

      4 - CABOT CORP (0000016040) (Issuer)

      3/18/25 5:30:12 PM ET
      $CBT
      Major Chemicals
      Industrials

    $CBT
    Leadership Updates

    Live Leadership Updates

    See more
    • Cabot Corporation Announces Election of Thierry Vanlancker to Board of Directors

      Cabot Corporation (NYSE:CBT) announced today that Thierry Vanlancker has been elected to its Board of Directors, effective July 12, 2024. He was also appointed a member of the Audit Committee of the Board of Directors, effective July 12, 2024. Prior to his retirement, Mr. Vanlancker was Chief Executive Officer and a Director of AkzoNobel NV, a multinational paints and coatings company, from 2017 to 2022. Prior to joining AkzoNobel, Mr. Vanlancker was President of Fluoroproducts and the EMEA region at The Chemours Company, a global provider of performance chemicals, from 2015 to 2016, and from 1988 to 2015 held various positions within the chemicals company Dupont. Mr. Vanlancker has been a

      7/12/24 4:15:00 PM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation Commended by the International Carbon Black Association for Outstanding Safety Performance

      19 Carbon Black Facilities Across Global Network Receive Safety Awards Cabot Corporation (NYSE:CBT) today announced that 19 of its 20 carbon black manufacturing sites have been recognized by the International Carbon Black Association's (ICBA) Safety Performance Recognition Program. Across the company's global network, 18 of its carbon black facilities received the gold award, the highest recognition available, and one received the bronze award for their outstanding safety performance in 2023. For the industry overall, a total of 35 ICBA member manufacturing facilities were recognized for above average safety performance, with Cabot achieving over half of all awards granted as well as the

      7/10/24 9:00:00 AM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation Announces Changes to Board of Directors

      Cabot Corporation (NYSE:CBT) announced today that Michelle Williams, Ph.D., has been elected to its Board of Directors, effective September 13, 2023. She was also appointed a member of the Audit Committee of the Board of Directors, effective September 13, 2023. Prior to her retirement in 2021, Dr. Williams was Global Group President of Altuglas International, a manufacturer of polymethyl methacrylate (PMMA) and a subsidiary of Arkema S.A., a manufacturer of specialty chemicals and advanced materials. Dr. Williams has been a Director of Brady Corporation, a manufacturer and supplier of identification solutions and workplace safety products, since 2019, where she serves as Chair of the Techno

      9/15/23 12:52:00 PM ET
      $CBT
      Major Chemicals
      Industrials

    $CBT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Cabot Corporation

      10-Q - CABOT CORP (0000016040) (Filer)

      5/7/25 12:37:39 PM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form S-8 POS filed by Cabot Corporation

      S-8 POS - CABOT CORP (0000016040) (Filer)

      4/7/25 9:33:44 AM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form S-8 POS filed by Cabot Corporation

      S-8 POS - CABOT CORP (0000016040) (Filer)

      4/7/25 9:33:04 AM ET
      $CBT
      Major Chemicals
      Industrials